CollaMedix
CollaMedix: Providing innovative collagen-based medical devices for women's urinary incontinence.
Founded
2018CollaMedix: Providing innovative collagen-based medical devices for women's urinary incontinence.
CollaMedix Inc. was founded to commercialize novel collagen-based electrocompaction technology developed at Case Western Reserve University (CWRU). The company, incorporated in June, focuses on providing innovative medical devices to treat stress urinary incontinence in women. Their core mission is to enhance the quality of life for women suffering from urine leakage due to activities like laughing, coughing, and exercising. CollaMedix offers proprietary collagen-based materials designed to provide structural support to human tissue.
Notable affiliated individuals include Ozan Akkus, PhD, Professor of Mechanical and Aerospace Engineering at CWRU and the Chief Scientific Officer, and founders Donna Richardson, CEO, and Subba Shankar, PhD, CTO. The company has exclusively licensed patents invented by Akkus. CollaMedix's key achievements include the successful development and commercialization of their unique collagen-based medical devices. Their impact lies in offering a non-invasive solution to a common yet often under-treated condition, significantly improving patients' quality of life.
Companies similar to CollaMedix include Uromedica, GeniPhys, Clozex Medical and CrossCoat Medical.
CollaMedix was founded in 2018.
CollaMedix's headquarters is located in Cleveland, OH, US.
CollaMedix's most recent funding round was for $987.9k (USD) in August 2021.
As of Aug 26, 2021, CollaMedix has disclosed funding of $1.2M (USD). Undisclosed round amounts are excluded.
CollaMedix has 9 employees as of Feb 4, 2024.
CrossCoat Medical
